基于“脾瘅”理论的高尿酸血症中医辨治理论探析
A Theoretical Exploration of Traditional Chinese Medicine Treatment for Hyperuricemia Based on the Theory of “Pi Dan”
DOI: 10.12677/acm.2025.15113301, PDF,   
作者: 王 钊:黑龙江中医药大学附属第一医院肾病科,黑龙江 哈尔滨;桑希生*:黑龙江中医药大学基础医学院,黑龙江 哈尔滨
关键词: 高尿酸血症脾瘅痛风代谢综合征代谢性炎症Hyperuricemia Pi Dan Gout Metabolic Syndrome Metabolic Inflammation
摘要: 基于“脾瘅”理论,对高尿酸血症的中医辨治进行了系统梳理与理论探析。通过阐释脾瘅的概念及病因病机,明确其与代谢综合征、高尿酸血症之间的内在联系。脾瘅的核心病机是中满内热(瘅热壅积)所致的膏脂精微及嘌呤代谢紊乱。结合现代医学视角,瘅热壅滞血分、脾失健运、肠肾失司是高尿酸血症发生发展的关键机制。治法上认为在清利中下二焦、促进尿酸排泄的基础思路上,可配合健运脾气、运通血脉的治法以促进代谢、清消瘅热,改善尿酸的生成与排泄失衡。
Abstract: Grounded in the theory of Pi Dan, this work offers a systematic synthesis and theoretical exploration of the traditional Chinese medicine (TCM) pattern differentiation and treatment of hyperuricemia. By elucidating the concept and etiopathogenesis of Pi Dan, it clarifies the intrinsic links between Pi Dan, metabolic syndrome, and hyperuricemia. Central to “Pi Dan” is internal heat accumulation (“Dan Re”), disrupting lipid metabolism and uric acid balance. From a modern medical perspective, Dan Re congesting the blood aspect, failure of the spleen’s transportation and transformation, and dysregulation of intestinal-renal governance are key mechanisms in the onset and progression of hyperuricemia. Therapeutically, on the foundation of clearing and disinhibiting the middle and lower jiao to promote uricacid excretion, one may combine methods that fortify spleenQi and its transportive function and that course the vessels, so as to enhance metabolism, clear and dissipate Dan Re, and rectify the imbalance between uricacid production and excretion.
文章引用:王钊, 桑希生. 基于“脾瘅”理论的高尿酸血症中医辨治理论探析[J]. 临床医学进展, 2025, 15(11): 1917-1925. https://doi.org/10.12677/acm.2025.15113301

参考文献

[1] 方宁远, 吕力为, 吕晓希, 等. 中国高尿酸血症相关疾病诊疗多学科专家共识(2023年版) [J]. 中国实用内科杂志, 2023, 43(6): 461-480.
[2] 王冰. 黄帝内经素问[M]. 北京: 人民卫生出版社, 1963: 261, 203.
[3] 袁卓喜, 司徒旋子. 论《黄帝内经》中“瘅”的含义及其英译[J]. 亚太传统医药, 2024, 20(8): 212-216.
[4] 郑景辉, 陈旋, 黄飞剑, 等. 脾瘅郁热阶段医案用药规律数据挖掘——基于《脾瘅新论-代谢综合征的中医认识及治疗》[J]. 中医杂志, 2021, 62(9): 755-763.
[5] 张志聪. 黄帝内经集注[M]. 北京: 中医古籍出版社, 2015: 187.
[6] Yanai, H., Adachi, H., Hakoshima, M. and Katsuyama, H. (2021) Molecular Biological and Clinical Understanding of the Pathophysiology and Treatments of Hyperuricemia and Its Association with Metabolic Syndrome, Cardiovascular Diseases and Chronic Kidney Disease. International Journal of Molecular Sciences, 22, Article No. 9221. [Google Scholar] [CrossRef] [PubMed]
[7] 董宿. 奇效良方[M]. 北京: 中国中医药出版社, 1995: 78.
[8] 李用粹. 证治汇补[M]. 北京: 人民卫生出版社, 2006: 224.
[9] Kim, S., Lee, S., Kim, Y., Kim, S., Seo, J., Choi, Y., et al. (2015) Hyperuricemia-Induced NLRP3 Activation of Macrophages Contributes to the Progression of Diabetic Nephropathy. American Journal of Physiology-Renal Physiology, 308, F993-F1003. [Google Scholar] [CrossRef] [PubMed]
[10] Qin, Y., Zhang, X., Tao, H., Wu, Y., Yan, J., Liao, L., et al. (2021) Ameliorative Effect and Mechanism of Yi‐Suan‐Cha against Hyperuricemia in Rats. Journal of Clinical Laboratory Analysis, 35, e23859. [Google Scholar] [CrossRef] [PubMed]
[11] 龚廷贤. 万病回春[M]. 北京: 人民卫生出版社, 2007: 306.
[12] 张璐. 张氏医通[M]. 上海: 第二军医大学出版社, 2006: 215.
[13] 辛家东, 周嘉宝, 吴志远, 等. 尿酸排泄及其相关转运蛋白在高尿酸血症中的研究进展[J]. 中国全科医学, 2023, 26(15): 1916-1922.
[14] Dehghan, A., van Hoek, M., Sijbrands, E.J.G., Hofman, A. and Witteman, J.C.M. (2008) High Serum Uric Acid as a Novel Risk Factor for Type 2 Diabetes. Diabetes Care, 31, 361-362. [Google Scholar] [CrossRef] [PubMed]
[15] 樊明媛, 袁久术, 谢红艳, 等. 肠道微生态在高尿酸血症中的作用机制及中医药干预研究进展[J]. 中国实验方剂学杂志, 2025, 31(5): 329-338.
[16] Wen, H., Ting, J.P. and O’Neill, L.A.J. (2012) A Role for the NLRP3 Inflammasome in Metabolic Diseases—Did Warburg Miss Inflammation? Nature Immunology, 13, 352-357. [Google Scholar] [CrossRef] [PubMed]
[17] Miller, S.G., Matias, C., Hafen, P.S., Law, A.S., Witczak, C.A. and Brault, J.J. (2024) Uric Acid Formation Is Driven by Crosstalk between Skeletal Muscle and Other Cell Types. JCI Insight, 9, e171815.
[18] 周学海. 周学海医学全书[M]. 北京: 中国中医药出版社, 2015: 272.
[19] 张景岳. 景岳全书[M]. 太原: 山西科学技术出版社, 2011: 264.
[20] 仝小林, 刘文科. 论膏浊病[J]. 中医杂志, 2011, 52(10): 816-818.
[21] 胡梁深, 谈荣珍, 范少勇, 等. 四妙丸加味方联合塞来昔布治疗痛风性关节炎(湿热蕴阻型)的临床疗效观察[J]. 广州中医药大学学报, 2021, 38(8): 1617-1620.
[22] 柏胜男, 汪孟曦, 甘莹, 等. 中医辨证方剂治疗高尿酸血症的研究进展[J]. 中医药导报, 2025, 31(7): 121-124.
[23] 刘维. 痛风及高尿酸血症中西医结合诊疗指南[J]. 中医杂志, 2023, 64(1): 98-106.
[24] 梁巧静, 梁维萍, 李琼, 等. 土茯苓抗痛风作用研究进展[J]. 世界中医药, 2018, 13(11): 2937-2940.
[25] 赵金悦, 李佳芮, 谢娜, 等. 重构本草——秦皮[J]. 长春中医药大学学报, 2024, 40(6): 609-611.
[26] Chen, L., Luo, Z., Wang, M., Cheng, J., Li, F., Lu, H., et al. (2021) The Efficacy and Mechanism of Chinese Herbal Medicines in Lowering Serum Uric Acid Levels: A Systematic Review. Frontiers in Pharmacology, 11, Article ID: 578318. [Google Scholar] [CrossRef] [PubMed]
[27] 黄元御. 素问悬解[M]. 北京: 中国医药科技出版社, 2024: 12.
[28] Hou, Y., Ma, R., Gao, S., Kaudimba, K.K., Yan, H., Liu, T., et al. (2021) The Effect of Low and Moderate Exercise on Hyperuricemia: Protocol for a Randomized Controlled Study. Frontiers in Endocrinology (Lausanne), 12, Article ID: 716802. [Google Scholar] [CrossRef] [PubMed]
[29] 张丽芬, 赵进喜. 中药鬼箭羽研究近况[J]. 中国中药杂志, 2005, 12(24): 1895-1898.
[30] 杜雨璇, 谢治深, 徐江雁, 等. 鬼箭羽化学成分和药理作用的研究进展及其质量标志物预测[J]. 天然产物研究与开发, 2024, 36(6): 1064-1081.
[31] 桑婷婷, 郭铖洁, 郭丹丹, 等. 中医药通过调节肠道菌群抑制肥胖和炎症相关疾病的进展研究[J]. 中国中药杂志, 2018, 43(16): 3235-3242.
[32] Luo, Y., Qian, X., Jiang, Y. and Jiang, Y. (2023) The Anti-Hyperuricemia and Anti-Inflammatory Effects of Atractylodes macrocephala in Hyperuricemia and Gouty Arthritis Rat Models. Combinatorial Chemistry & High Throughput Screening, 26, 950-964. [Google Scholar] [CrossRef] [PubMed]